96 related articles for article (PubMed ID: 8417251)
21. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA
Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274
[TBL] [Abstract][Full Text] [Related]
22. Change in relative mobility of M protein following neuraminidase treatment in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Kurihara Y; Iijima S; Fukushima K; Hosaka T; Shiba K
J Clin Lab Anal; 2004; 18(3):182-6. PubMed ID: 15103683
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow immunohistology of plasma cell neoplasms.
Wei A; Juneja S
J Clin Pathol; 2003 Jun; 56(6):406-11. PubMed ID: 12783964
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal gammopathy of undetermined significance: new insights.
Chen BH
CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
[No Abstract] [Full Text] [Related]
25. Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.
Riccardi A; Mora O; Tinelli C; Valentini D; Brugnatelli S; Spanedda R; De Paoli A; Barbarano L; Di Stasi M; Giordano M; Delfini C; Nicoletti G; Bergonzi C; Rinaldi E; Piccinini L; Ascari E
Br J Cancer; 2000 Apr; 82(7):1254-60. PubMed ID: 10755397
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis.
Kurihara Y; Shiba K; Fukumura Y; Kobayashi I; Kamei S
J Clin Lab Anal; 2000; 14(2):64-9. PubMed ID: 10683616
[TBL] [Abstract][Full Text] [Related]
27. Current drug therapy for multiple myeloma.
Huang YW; Hamilton A; Arnuk OJ; Chaftari P; Chemaly R
Drugs; 1999 Apr; 57(4):485-506. PubMed ID: 10235689
[TBL] [Abstract][Full Text] [Related]
28. Pancreatitis associated with pleural-mediastinal pseudocyst, panniculitis and polyarthritis.
López A; García-Estañ J; Marras C; Castaño M; Rojas MJ; Garre C; Gómez J
Clin Rheumatol; 1998; 17(4):335-9. PubMed ID: 9776120
[TBL] [Abstract][Full Text] [Related]
29. ["Benign" monoclonal gammopathy and chronic lymphatic leukemia in a patient with Noonan syndrome].
Riederer J
Med Klin (Munich); 1998 Jul; 93(7):433-7. PubMed ID: 9711057
[TBL] [Abstract][Full Text] [Related]
30. Multiple myeloma: VI International Workshop, June 14-18, 1997, Boston, Massachusetts, USA.
Bergenbrant S
Med Oncol; 1998 Apr; 15(1):1-5. PubMed ID: 9643523
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
32. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
33. Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma.
Laroche M; Attal M; Dromer C
Clin Rheumatol; 1996 Jul; 15(4):347-52. PubMed ID: 8853167
[TBL] [Abstract][Full Text] [Related]
34. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
35. "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.
Kyle RA
Mayo Clin Proc; 1993 Jan; 68(1):26-36. PubMed ID: 8417251
[TBL] [Abstract][Full Text] [Related]
36. Current concepts on monoclonal gammopathies.
Kyle RA
Aust N Z J Med; 1992 Jun; 22(3):291-302. PubMed ID: 1497556
[TBL] [Abstract][Full Text] [Related]
37. 'Benign' monoclonal gammopathy. A misnomer?
Kyle RA
JAMA; 1984 Apr; 251(14):1849-54. PubMed ID: 6422066
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal gammopathy of undetermined significance.
Kyle RA
Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
[TBL] [Abstract][Full Text] [Related]
40. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
